perhexiline has been researched along with niclosamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Balgi, AD; Donohue, E; Fonseca, BD; Lajoie, P; Nabi, IR; Proud, CG; Roberge, M; Tsang, TC | 1 |
2 other study(ies) available for perhexiline and niclosamide
| Article | Year |
|---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |
Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.
Topics: Acetophenones; Amiodarone; Antinematodal Agents; Automation; Autophagy; Benzopyrans; Cardiovascular Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Mechanistic Target of Rapamycin Complex 1; Models, Chemical; Multiprotein Complexes; Niclosamide; Nutritional Sciences; Perhexiline; Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factors | 2009 |